Dragonfly Therapeutics

Dragonfly Therapeutics is a clinical-stage biotechnology company based in Waltham, Massachusetts, founded in 2016 by Tyler Jacks, Bill Haney and David Raulet to develop natural killer (NK) cell-based immunotherapies. Its proprietary TriNKET (Tri-specific NK cell Engager Therapy) and cytokine engager platforms produce molecules that bind both a tumor or disease antigen and an NK cell activating receptor, recruiting innate and adaptive immunity against cancer, autoimmune disease, fibrosis and neuro-inflammation. Lead clinical candidate DF1001 targets HER2 in advanced solid tumors, and the platform is licensed under multi-target collaborations with AbbVie, Bristol Myers Squibb, Merck and Gilead. Dragonfly is a therapeutics developer rather than a software company: it publishes no developer program, no public API, no SDKs and no machine-readable API contract. The only agent-readable surfaces on its own host are the llms.txt and Model Context Protocol endpoint automatically provisioned by its Wix website platform.

Dragonfly Therapeutics publishes 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Immunotherapy, and Oncology.

Dragonfly Therapeutics’ developer surface includes engineering blog, product news, authentication, and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.5/100 emerging ▬ flat Agent 14/100 agent aware saas Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0

1 APIs 1 MCP Servers

Company Biotechnology Pharmaceuticals Immunotherapy Oncology Life Sciences Clinical Stage Drug Discovery Healthcare

Kin Score

Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0

Composite quality — 15.5/100 · emerging

Contract Quality 0.0 / 21

Developer Ergonomics 2.4 / 17

Access Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Contract Governance 1.9 / 10

Discoverability 6.1 / 9

Regulatory Posture 3.9 / 15

Agent readiness — 14/100 · agent aware

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 12 / 12

Machine-Readable Auth 10 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 7 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/dragonfly-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

APIs 1

Individual APIs this provider publishes, each with its own machine-readable definition.

Dragonfly Therapeutics Site MCP

Model Context Protocol endpoint served from the Dragonfly Therapeutics website host. This is a platform-provided surface automatically provisioned by Wix for every site it build...

MCP Servers 1

Model Context Protocol servers that expose these APIs to AI agents.

Dragonfly Therapeutics MCP Server

MCP SERVER

Pricing Plans 1

Published pricing tiers and plan structures.

Dragonfly Therapeutics Plans Pricing

0 plans

PLANS

Rate Limits 1

Documented rate limits and quota policies.

Dragonfly Therapeutics Rate Limits

0 limits

RATE LIMITS

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Dragonfly Therapeutics Authentication

none/bearer-visitor-token · 2 schemes

SECURITY

Dragonfly Therapeutics Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 2

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

MCPServer

MCPServer

Design & Contract 1

Pagination, idempotency, versioning, errors, and events

Conformance

Conformance

Access & Security 2

Authentication, authorization, and security posture

Authentication

Authentication

DomainSecurity

DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

Blog

BlogRSS

News

LinkedIn

Other 1

Properties that don't map to a standard resource type

Profile

Profile

Source (apis.yml)

aid: dragonfly-therapeutics
name: Dragonfly Therapeutics
description: 'Dragonfly Therapeutics is a clinical-stage biotechnology company based in Waltham, Massachusetts, founded in
  2016 by Tyler Jacks, Bill Haney and David Raulet to develop natural killer (NK) cell-based immunotherapies. Its proprietary
  TriNKET (Tri-specific NK cell Engager Therapy) and cytokine engager platforms produce molecules that bind both a tumor or
  disease antigen and an NK cell activating receptor, recruiting innate and adaptive immunity against cancer, autoimmune disease,
  fibrosis and neuro-inflammation. Lead clinical candidate DF1001 targets HER2 in advanced solid tumors, and the platform
  is licensed under multi-target collaborations with AbbVie, Bristol Myers Squibb, Merck and Gilead. Dragonfly is a therapeutics
  developer rather than a software company: it publishes no developer program, no public API, no SDKs and no machine-readable
  API contract. The only agent-readable surfaces on its own host are the llms.txt and Model Context Protocol endpoint automatically
  provisioned by its Wix website platform.'
url: https://raw.githubusercontent.com/api-evangelist/dragonfly-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  probe_state: none
  source:
  - authentication
  - rate-limits
  - security
  generated: '2026-09-03'
  method: derived
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Immunotherapy
- Oncology
- Life Sciences
- Clinical Stage
- Drug Discovery
- Healthcare
apis:
- name: Dragonfly Therapeutics Site MCP
  description: 'Model Context Protocol endpoint served from the Dragonfly Therapeutics website host. This is a platform-provided
    surface automatically provisioned by Wix for every site it builds — not a first-party Dragonfly Therapeutics product API.
    It answers an unauthenticated JSON-RPC 2.0 tools/list with nine tools that let an agent read business details, search
    site content, obtain a visitor token and call Wix site APIs on a visitor''s behalf. Verified live on 2026-08-12: tools/list
    returned HTTP 200 with real inputSchema per tool, and a GetBusinessDetails call returned the site''s business record.'
  humanURL: https://www.dragonflytx.com/
  baseURL: https://www.dragonflytx.com/_api/mcp
  tags:
  - MCP
  - Agents
  - Website
  tags_raw:
  - MCP
  - Agent
  - Website
  properties:
  - type: MCPServer
    url: mcp/dragonfly-therapeutics-mcp.yml
  - type: Authentication
    url: authentication/dragonfly-therapeutics-authentication.yml
  - type: RateLimits
    url: rate-limits/dragonfly-therapeutics-rate-limits.yml
  - type: Plans
    url: plans/dragonfly-therapeutics-plans-pricing.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.dragonflytx.com/
- type: Blog
  url: https://www.dragonflytx.com/blog
- type: BlogRSS
  url: https://www.dragonflytx.com/blog-feed.xml
- type: News
  url: https://www.dragonflytx.com/news
- type: PrivacyPolicy
  url: https://www.dragonflytx.com/_files/ugd/cb0357_e5861f3f611f4e3091162162753c2083.pdf
- type: LinkedIn
  url: https://www.linkedin.com/company/dragonfly-therapeutics-inc.
- type: Profile
  name: Hiive secondary-market listing
  url: https://www.hiive.com/securities/dragonfly-therapeutics-stock
- type: LLMsTxt
  url: llms/dragonfly-therapeutics-llms.txt
- type: MCPServer
  url: mcp/dragonfly-therapeutics-mcp.yml
- type: Authentication
  url: authentication/dragonfly-therapeutics-authentication.yml
- type: Conformance
  url: conformance/dragonfly-therapeutics-conformance.yml
- type: DomainSecurity
  url: security/dragonfly-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 9
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Dragonfly Therapeutics is a clinical-stage NK-cell immunotherapy developer whose product is a drug pipeline, not
    software; the whole site is ten Wix pages with no developer, API or docs route, and the only machine-readable surfaces
    (llms.txt and a /_api/mcp endpoint) are boilerplate auto-provisioned by Wix rather than anything the company authored.
  evidence:
  - url: https://www.dragonflytx.com/developers
    status: 404
  - url: https://www.dragonflytx.com/api-docs
    status: 404
  - url: https://www.dragonflytx.com/openapi.json
    status: 400
  - url: https://www.dragonflytx.com/.well-known/agent-card.json
    status: 400
  - url: https://www.dragonflytx.com/llms.txt
    status: 200
  - url: https://www.dragonflytx.com/_api/mcp
    status: 200
  checked: '2026-08-12'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/dragonfly-therapeutics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/dragonfly-therapeutics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/dragonfly-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.